NCT05938829 (FAME) is a NA clinical trial of Ultrasound following the SMFM guidelines in Fetal Growth Retardation, sponsored by The University of Texas Health Science Center, Houston.

Who is sponsoring NCT05938829?

NCT05938829 is sponsored by The University of Texas Health Science Center, Houston.

What drugs are being tested in NCT05938829?

Interventions in NCT05938829: Ultrasound following the SMFM guidelines, Ultrasound following the ISUOG guidelines.

What condition does NCT05938829 study?

NCT05938829 studies Fetal Growth Retardation.

Is NCT05938829 still recruiting?

NCT05938829 is currently status unknown. Last updated 11 July 2023.

Last reviewed 2023-07-11 · How we verify

NCT05938829: FAME

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Fetal Growth Restriction: Management Using Two Guidelines - Fetal Growth Antenatal Management Evaluation

Status unknown NA Last updated 11 July 2023

What this trial tests

NA trial testing Ultrasound following the SMFM guidelines in Fetal Growth Retardation in 1,100 participants. Status unknown.

Timeline

1 July 2023

Primary endpoint
15 July 2025

1 December 2025

Quick facts

Lead sponsor	The University of Texas Health Science Center, Houston
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	diagnostic
Enrollment	1,100
Start date	1 July 2023
Primary completion	15 July 2025
Estimated completion	1 December 2025
Sites	1 location across United States

Drugs / interventions tested

Ultrasound following the SMFM guidelines
Ultrasound following the ISUOG guidelines

Conditions studied

Fetal Growth Retardation — all drugs for Fetal Growth Retardation →

Sponsor

The University of Texas Health Science Center, Houston

Who can join

Eligibility, any sex, with Fetal Growth Retardation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to compare the composite neonatal adverse outcomes (CNAO) among pregnancies complicated by fetal growth restriction (FGR) managed using the Society of Maternal-Fetal Medicine (SMFM) versus International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) antepartum ultrasound guidelines, to measure the rate of the individual components of CNAO, to record the rate of cesarean delivery during labor, to tabulate the rate of deviation from the management protocol assigned at the time of evaluation, to record neonatal intensive care unit (NICU) admission rates and to measure the rate of the composite maternal adverse outcome (CMAO).

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Fetal Growth Retardation

Currently open trials in the same condition.

NCT06952777 — Validation of Sensors for Long-term Non-Invasive Fetal Monitoring · NA · recruiting
NCT06405360 — DEUX OEUFs: Cracking the Potential of Eggs to Improve Child Growth and Development · NA · active not recruiting
NCT06096805 — Prediction of Placental Fetal Growth Restriction in High Risk Population (PoPFGR) · recruiting
NCT06215690 — Evaluation of Anterior Middle Brain Structures With Cerebrovascular Flow in Fetuses With Fetal Growth Restriction · active not recruiting
NCT06416995 — Serum Vasohibin, Cardiotrophin, Endocan & Perinatal Outcomes · recruiting

Other The University of Texas Health Science Center, Houston trials

Trials by the same sponsor.

NCT04200729 — Povidone-iodine Irrigation for Prevention of Intra-abdominal Abscess in Pediatric Perforated Appendicitis: a Multi-cente · Phase 4 · not yet recruiting
NCT07225062 — Improving HIV Prevention and Substance Use Post-Sexual Assault Services · NA · not yet recruiting
NCT07396974 — Increasing Treatment Access in Trauma Exposed Children: Developing an Adapted Step One Intervention (RCT) · NA · not yet recruiting
NCT07170163 — Navigating the Transition to Adulthood: A Dual Language Mobile App for Latino Youth With ASD and Their Families · NA · not yet recruiting
NCT06915441 — Lipid Infusions to Optimize Nutrition Trial · Phase 2 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05938829 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by The University of Texas Health Science Center, Houston
Last refreshed: 11 July 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05938829.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing